Kornélia Polyák

77.6k total citations · 25 hit papers
202 papers, 49.8k citations indexed

About

Kornélia Polyák is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kornélia Polyák has authored 202 papers receiving a total of 49.8k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Molecular Biology, 119 papers in Oncology and 69 papers in Cancer Research. Recurrent topics in Kornélia Polyák's work include Cancer Cells and Metastasis (50 papers), Cancer Genomics and Diagnostics (44 papers) and Epigenetics and DNA Methylation (35 papers). Kornélia Polyák is often cited by papers focused on Cancer Cells and Metastasis (50 papers), Cancer Genomics and Diagnostics (44 papers) and Epigenetics and DNA Methylation (35 papers). Kornélia Polyák collaborates with scholars based in United States, United Kingdom and South Korea. Kornélia Polyák's co-authors include Robert A. Weinberg, Andriy Marusyk, Joan Massagué, Bert Vogelstein, Kenneth W. Kinzler, Mary W. Brooks, Vanessa Almendro, Andrew Koff, Michail Shipitsin and Ayyakkannu Ayyanan and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Kornélia Polyák

197 papers receiving 48.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

2008 6.9k citations Michail Shipitsin, Kornélia Polyák et al. profile →
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

2009 2.7k citations Kornélia Polyák et al. profile →
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

2007 2.5k citations Kornélia Polyák et al. profile →
A model for p53-induced apoptosis

1997 2.1k citations Kornélia Polyák et al. profile →
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1994 1.9k citations Kornélia Polyák et al. profile →
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

1994 1.7k citations Kornélia Polyák et al. profile →
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

1998 1.5k citations Kornélia Polyák et al. profile →
Intra-tumour heterogeneity: a looking glass for cancer?

2012 1.4k citations Andriy Marusyk, Vanessa Almendro et al. profile →
A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 -Deficient Mice

1996 1.3k citations Kornélia Polyák et al. profile →
Tumor heterogeneity: Causes and consequences

2009 1.2k citations Andriy Marusyk, Kornélia Polyák profile →
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex

1995 1.1k citations Kornélia Polyák et al. profile →
Molecular characterization of the tumor microenvironment in breast cancer

2004 1.0k citations Cameron Brennan, Stuart J. Schnitt et al. profile →
Is a p53-Regulated Inhibitor of G2/M Progression

1997 1.0k citations Kornélia Polyák et al. profile →
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment

2019 964 citations Ana C. Garrido-Castro, Kornélia Polyák et al. Cancer Discovery profile →
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state

2011 897 citations Ying Su, Kornélia Polyák et al. profile →
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

1995 833 citations Kornélia Polyák et al. profile →
lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin

1994 805 citations Kornélia Polyák et al. profile →
Heterogeneity in breast cancer

2011 769 citations Kornélia Polyák profile →
Somatic mutations of the mitochondrial genome in human colorectal tumours

1998 689 citations Kornélia Polyák et al. profile →
Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation

1994 664 citations Kornélia Polyák et al. profile →
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance

2020 581 citations Andriy Marusyk, Michalina Janiszewska et al. profile →
Ductal Carcinoma in Situ of the Breast

2004 529 citations Kornélia Polyák et al. profile →
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

2013 471 citations Kornélia Polyák, Joe W. Gray et al. profile →
Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity

2014 417 citations Andriy Marusyk, Doris P. Tabassum et al. profile →
Tumorigenesis: it takes a village

2015 407 citations Doris P. Tabassum, Kornélia Polyák profile →

Peers

Countries citing papers authored by Kornélia Polyák

Since Specialization

Citations

This map shows the geographic impact of Kornélia Polyák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kornélia Polyák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kornélia Polyák more than expected).

Fields of papers citing papers by Kornélia Polyák

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kornélia Polyák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kornélia Polyák. The network helps show where Kornélia Polyák may publish in the future.

Co-authorship network of co-authors of Kornélia Polyák

This figure shows the co-authorship network connecting the top 25 collaborators of Kornélia Polyák. A scholar is included among the top collaborators of Kornélia Polyák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kornélia Polyák. Kornélia Polyák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3 2024 ·Nature Cell Biology ·Marco Seehawer, Zheqi Li, Jun Nishida, Pierre Foidart, (unknown), (unknown), Marie-Anne Goyette, Pengze Yan, (unknown), (unknown), Paloma Cejas, Henry W. Long, Malvina Papanastasiou, Kornélia Polyák	21
2	A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer 2023 ·Nature Communications ·Connor Stashko, Mary-Kate Hayward, Jason J. Northey, Neil D. Pearson, Alastair Ironside, Johnathon N. Lakins, Roger Oria, Marie-Anne Goyette, (unknown), Hege G. Russnes, E. Shelley Hwang, Matthew L. Kutys, Kornélia Polyák, Valerie M. Weaver	36
3	Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer 2023 ·Molecular Cancer Therapeutics ·Maša Alečković, Zheqi Li, (unknown), Xintao Qiu, (unknown), Pierre Foidart, (unknown), (unknown), Shaokun Shu, Nikolas Kesten, Rong Li, Klothilda Lim, Ana C. Garrido-Castro, Jennifer L. Guerriero, Jun Qi, Henry W. Long, Kornélia Polyák	6
4	Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System 2020 ·Molecular Cancer Research ·Anne Trinh, Carlos R. Gil Del Alcazar, Sachet A. Shukla, Koei Chin, Young Hwan Chang, Guillaume Thibault, Jennifer Eng, Bojana Jovanović, C. Marcelo Aldaz, So Yeon Park, Joon Jeong, Catherine J. Wu, Joe W. Gray, Kornélia Polyák	24
5	EN1 Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain Metastasis 2019 ·Cancer Research ·Guillermo Peluffo, Ashim Subedee, Nicholas W. Harper, Natalie L. Kingston, Bojana Jovanović, (unknown), Laura E. Stevens, Francisco Beça, Anne Trinh, Chandra Sekhar Reddy Chilamakuri, Evangelia K. Papachristou, Katherine C. Murphy, Ying Su, Andriy Marusyk, Clive S. D’Santos, Oscar M. Rueda, Andrew H. Beck, Carlos Caldas, Jason S. Carroll, Kornélia Polyák	47
6	The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women 2016 ·Cancer Research ·Sung Jin Huh, Hannah Oh, Michael Peterson, Vanessa Almendro, Rong Hu, Michaela Bowden, (unknown), Maura B. Cotter, Massimo Loda, William T. Barry, Kornélia Polyák, Rulla M. Tamimi	41
7	Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes 2016 ·Cancer Research ·Andriy Marusyk, Doris P. Tabassum, Michalina Janiszewska, Andrew E. Place, Anne Trinh, Andrii I. Rozhok, Saumyadipta Pyne, Jennifer L. Guerriero, Shaokun Shu, Muhammad B. Ekram, (unknown), Daniel P. Cahill, Yuri Nikolsky, Timothy A. Chan, Mothaffar F. Rimawi, Susan G. Hilsenbeck, Rachel Schiff, Kent C. Osborne, Antony Letai, Kornélia Polyák	96
8	CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer 2015 ·Cancer Research ·Taku Yoshida, Jee Hyun Kim, Kristopher Carver, Ying Su, Stanislawa Weremowicz, (unknown), S Yamamoto, Cameron Brennan, Shenglin Mei, Henry W. Long, Jun Yao, Kornélia Polyák	84
9	HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance 2015 ·Cancer Discovery ·Kideok Jin, Sunju Park, Wei Wen Teo, Preethi Korangath, Soonweng Cho, Takahiro Yoshida, Balázs Győrffy, Chirayu Goswami, Harikrishna Nakshatri, (unknown), Weiqiang Zhou, Hongkai Ji, Ying Su, Muhammad B. Ekram, Zhengsheng Wu, Tao Zhu, Kornélia Polyák, Saraswati Sukumar	67
10	Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer 2015 ·Cancer Research ·Byunghee Yoo, Amol Kavishwar, Alana Ross, Ping Wang, Doris P. Tabassum, Kornélia Polyák, (unknown), Victoria Petkova, Pamela Pantazopoulos, Aseda Tena, Anna Moore, Zdravka Medarova	65
11	Genetic and Phenotypic Diversity in Breast Tumor Metastases 2014 ·Cancer Research ·Vanessa Almendro, Hee Jung Kim, Yu-Kang Cheng, Mithat Gönen, Shalev Itzkovitz, Pedram Argani, Alexander van Oudenaarden, Saraswati Sukumar, Franziska Michor, Kornélia Polyák	129
12	Targeting Akt3 Signaling in Triple-Negative Breast Cancer 2013 ·Cancer Research ·Y. Rebecca Chin, Taku Yoshida, Andriy Marusyk, Andrew H. Beck, Kornélia Polyák, Alex Toker	127
13	Evolutionary Pathways in BRCA1-Associated Breast Tumors 2012 ·Cancer Discovery ·Filipe Correia Martins, Subhajyoti De, Vanessa Almendro, Mithat Gönen, So Yeon Park, Joanne L. Blum, (unknown), (unknown), Stuart J. Schnitt, Nadine Tung, Judy E. Garber, (unknown), Franziska Michor, Kornélia Polyák	95
14	Functional Synergies yet Distinct Modulators Affected by Genetic Alterations in Common Human Cancers 2011 ·Cancer Research ·Marina Bessarabova, (unknown), Weiwei Shi, (unknown), (unknown), Kornélia Polyák, Victor E. Velculescu, Tatiana Nikolskaya, Yuri Nikolsky	8
15	Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer 2010 ·Clinical Cancer Research ·So Yeon Park, Hee Eun Lee, Hailun Li, Michail Shipitsin, Rebecca Gelman, Kornélia Polyák	325
16	PIK3CA Mutations in In situ and Invasive Breast Carcinomas 2010 ·Cancer Research ·Alexander Miron, Mária Váradi, Daniel R. Carrasco, Hailun Li, Lauren Luongo, Hee Jung Kim, So Yeon Park, Eun Yoon Cho, (unknown), Sarah M. Kehoe, J. Dirk Iglehart, Deborah Dillon, D. Craig Allred, Laura E. MacConaill, Rebecca Gelman, Kornélia Polyák	107
17	Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression 2008 ·Clinical Cancer Research ·Celina G. Kleer, Noga Bloushtain-Qimron, Yu‐Hui Chen, Daniel R. Carrasco, Min Hu, Jun Yao, Stine‐Kathrein Kraeft, Laura C. Collins, Michael S. Sabel, Pedram Argani, Rebecca Gelman, Stuart J. Schnitt, Ian E. Krop, Kornélia Polyák	80
18	Cyclooxygenase-2 Expression during Immortalization and Breast Cancer Progression 2008 ·Cancer Research ·Xiangshan Zhao, (unknown), (unknown), Hui Ma, Hongyan Du, Jun Yao, Thomas A. Victor, Kornélia Polyák, Charles D. Sturgis, Hamid Band, Vimla Band	36
19	Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer 2008 ·Cancer Research ·Yuri Nikolsky, (unknown), Jun Yao, Damir Dosymbekov, (unknown), (unknown), Zoltán Dezső, (unknown), Laura E. MacConaill, Wendy Winckler, Tatiana Serebryiskaya, Tatiana Nikolskaya, Kornélia Polyák	69
20	Combined cDNA Array Comparative Genomic Hybridization and Serial Analysis of Gene Expression Analysis of Breast Tumor Progression 2006 ·Cancer Research ·Jun Yao, Stanislawa Weremowicz, Bin Feng, Robert Gentleman, Jeffrey R. Marks, Rebecca Gelman, Cameron Brennan, Kornélia Polyák	133

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact